Efficacy and Tolerance of Treatment With Bevacizumab for Severe Liver Involvement With High Cardiac Output in Hereditary Hemorrhagic Telangiectasia Within the French Hereditary Hemorrhagic Telangiectasia Network

Conditions

• Hereditary Hemorrhagic Telangiectasia (HHT)
• Pulmonary Hypertension
• Bevacizumab

Interventions

• DRUG: Bevacizumab

Sponsor

Poitiers University Hospital